Patents Assigned to DISPERSOME IP APS
  • Protein based excipient for active pharmaceutical ingredients
    Patent number: 12582717
    Abstract: Provided herein is a pharmaceutical formulation comprising a protein based excipient in combination with an active pharmaceutical ingredient (API) wherein said formulation is substantially amorphous and form a substantially homogenous mixture; and further a method for producing said pharmaceutical formulation; and said pharmaceutical formulation for use as a medicament.
    Type: Grant
    Filed: July 30, 2021
    Date of Patent: March 24, 2026
    Assignee: Dispersome IP APS
    Inventors: Bjorn Vergauwen, Guy Van De Mooter
  • Co-amorphous forms of beta-lactoglobulin and a drug substance
    Patent number: 12564554
    Abstract: The present invention relates to co-amorphous forms of a drug substance and a protein, more particularly beta-lactoglobulin, wherein the purity of the beta-lactoglobulin is at least 92% (w/w) of the total amount of protein comprised in the co-amorphous form. The present invention also relates to compositions, such as pharmaceutical compositions, comprising the co-amorphous form.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: March 3, 2026
    Assignee: DISPERSOME IP APS
    Inventors: Korbinian Löbmann, Donglei Leng, Ole Wiborg